Annual Shareholders Equity
-$626.00 K
+$553.00 K+46.90%
December 1, 2023
Summary
- As of February 7, 2025, KAPA annual stockholders equity is -$626.00 thousand, with the most recent change of +$553.00 thousand (+46.90%) on December 1, 2023.
- During the last 3 years, KAPA annual shareholders equity has fallen by -$283.20 thousand (-82.61%).
- KAPA annual shareholders equity is now -82.61% below its all-time high of -$342.80 thousand, reached on December 1, 2020.
Performance
KAPA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$3.33 M
+$4.22 M+476.50%
September 30, 2024
Summary
- As of February 7, 2025, KAPA quarterly stockholders equity is $3.33 million, with the most recent change of +$4.22 million (+476.50%) on September 30, 2024.
- Over the past year, KAPA quarterly shareholders equity has increased by +$3.96 million (+632.27%).
- KAPA quarterly shareholders equity is now at all-time high.
Performance
KAPA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
KAPA Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.9% | +632.3% |
| 3 y3 years | -82.6% | - |
| 5 y5 years | -82.6% | - |
KAPA Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +46.9% | at high | +313.4% |
| 5 y | 5-year | -82.6% | +46.9% | at high | +313.4% |
| alltime | all time | -82.6% | +46.9% | at high | +313.4% |
Kairos Pharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.33 M(-476.5%) |
| Jun 2024 | - | -$885.00 K(-3.7%) |
| Mar 2024 | - | -$919.00 K(+46.8%) |
| Dec 2023 | -$626.00 K | -$626.00 K(+35.2%) |
| Sep 2023 | - | -$463.00 K(-70.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -$1.56 M(+17.8%) |
| Mar 2023 | - | -$1.32 M(+12.4%) |
| Dec 2022 | -$1.18 M(+1.0%) | -$1.18 M |
| Dec 2021 | -$1.17 M(+240.4%) | - |
| Dec 2020 | -$342.80 K | - |
FAQ
- What is Kairos Pharma annual stockholders equity?
- What is the all time high annual shareholders equity for Kairos Pharma?
- What is Kairos Pharma annual shareholders equity year-on-year change?
- What is Kairos Pharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Kairos Pharma?
- What is Kairos Pharma quarterly shareholders equity year-on-year change?
What is Kairos Pharma annual stockholders equity?
The current annual shareholders equity of KAPA is -$626.00 K
What is the all time high annual shareholders equity for Kairos Pharma?
Kairos Pharma all-time high annual stockholders equity is -$342.80 K
What is Kairos Pharma annual shareholders equity year-on-year change?
Over the past year, KAPA annual stockholders equity has changed by +$553.00 K (+46.90%)
What is Kairos Pharma quarterly stockholders equity?
The current quarterly shareholders equity of KAPA is $3.33 M
What is the all time high quarterly shareholders equity for Kairos Pharma?
Kairos Pharma all-time high quarterly stockholders equity is $3.33 M
What is Kairos Pharma quarterly shareholders equity year-on-year change?
Over the past year, KAPA quarterly stockholders equity has changed by +$3.96 M (+632.27%)